Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipocytes | 14 | 2025 | 84 | 2.070 |
Why?
|
| Insulin Resistance | 14 | 2019 | 469 | 1.730 |
Why?
|
| Adipose Tissue | 6 | 2023 | 351 | 1.450 |
Why?
|
| Inflammation | 11 | 2024 | 542 | 1.240 |
Why?
|
| Vitis | 8 | 2016 | 13 | 1.060 |
Why?
|
| Lipid Metabolism | 3 | 2023 | 105 | 0.860 |
Why?
|
| Mice | 20 | 2025 | 2529 | 0.820 |
Why?
|
| Linoleic Acids, Conjugated | 4 | 2015 | 7 | 0.810 |
Why?
|
| Adiposity | 4 | 2016 | 199 | 0.800 |
Why?
|
| Liver | 6 | 2017 | 492 | 0.760 |
Why?
|
| Cholesterol | 4 | 2019 | 255 | 0.750 |
Why?
|
| Lipogenesis | 2 | 2017 | 18 | 0.750 |
Why?
|
| Signal Transduction | 8 | 2025 | 689 | 0.740 |
Why?
|
| Obesity | 9 | 2023 | 1179 | 0.700 |
Why?
|
| Hepatocytes | 2 | 2019 | 83 | 0.640 |
Why?
|
| Macrophages | 6 | 2019 | 195 | 0.620 |
Why?
|
| Adipogenesis | 3 | 2025 | 30 | 0.610 |
Why?
|
| Inflammation Mediators | 5 | 2013 | 102 | 0.600 |
Why?
|
| Plant Extracts | 5 | 2012 | 61 | 0.580 |
Why?
|
| Animals | 21 | 2025 | 7599 | 0.580 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 790 | 0.570 |
Why?
|
| Physical Conditioning, Animal | 3 | 2025 | 35 | 0.550 |
Why?
|
| Mice, Knockout | 5 | 2025 | 458 | 0.480 |
Why?
|
| G-Protein-Coupled Receptor Kinase 5 | 1 | 2025 | 1 | 0.450 |
Why?
|
| Fatty Acids | 4 | 2024 | 101 | 0.440 |
Why?
|
| Cell Differentiation | 2 | 2025 | 469 | 0.410 |
Why?
|
| Lipoproteins, HDL | 3 | 2019 | 254 | 0.410 |
Why?
|
| Lipolysis | 3 | 2023 | 17 | 0.410 |
Why?
|
| Fruit | 3 | 2012 | 56 | 0.380 |
Why?
|
| Stilbenes | 2 | 2010 | 21 | 0.370 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2010 | 69 | 0.350 |
Why?
|
| 3T3-L1 Cells | 3 | 2025 | 11 | 0.350 |
Why?
|
| Dietary Fats | 2 | 2017 | 109 | 0.320 |
Why?
|
| PPAR gamma | 5 | 2018 | 44 | 0.300 |
Why?
|
| Adipose Tissue, White | 3 | 2015 | 6 | 0.300 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2019 | 4 | 0.300 |
Why?
|
| Quercetin | 3 | 2012 | 8 | 0.300 |
Why?
|
| Gene Deletion | 2 | 2018 | 65 | 0.270 |
Why?
|
| Tobacco | 1 | 2018 | 58 | 0.270 |
Why?
|
| Triglycerides | 5 | 2018 | 229 | 0.260 |
Why?
|
| Weight Loss | 2 | 2018 | 462 | 0.240 |
Why?
|
| Male | 14 | 2025 | 19754 | 0.240 |
Why?
|
| Cells, Cultured | 7 | 2013 | 821 | 0.240 |
Why?
|
| Butter | 1 | 2015 | 2 | 0.240 |
Why?
|
| Nicotine | 1 | 2018 | 177 | 0.230 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2025 | 8 | 0.230 |
Why?
|
| Adipose Tissue, Brown | 1 | 2015 | 8 | 0.230 |
Why?
|
| Protein Sorting Signals | 1 | 2015 | 6 | 0.230 |
Why?
|
| Sphingosine | 1 | 2015 | 13 | 0.220 |
Why?
|
| Acute Lung Injury | 1 | 2025 | 37 | 0.220 |
Why?
|
| Lysophospholipids | 1 | 2015 | 24 | 0.220 |
Why?
|
| Muscular Atrophy | 1 | 2025 | 76 | 0.220 |
Why?
|
| Succinates | 1 | 2024 | 6 | 0.210 |
Why?
|
| Glucocorticoids | 1 | 2025 | 151 | 0.210 |
Why?
|
| Ethanolamines | 1 | 2023 | 10 | 0.200 |
Why?
|
| Estrenes | 1 | 2013 | 2 | 0.200 |
Why?
|
| Linoleic Acids | 1 | 2013 | 3 | 0.200 |
Why?
|
| Pyrrolidinones | 1 | 2013 | 5 | 0.200 |
Why?
|
| Type C Phospholipases | 1 | 2013 | 7 | 0.200 |
Why?
|
| Overweight | 1 | 2015 | 263 | 0.200 |
Why?
|
| Apolipoproteins | 1 | 2015 | 200 | 0.190 |
Why?
|
| Glucose Intolerance | 1 | 2012 | 46 | 0.190 |
Why?
|
| Calcium | 2 | 2013 | 323 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2011 | 213 | 0.190 |
Why?
|
| Sepsis | 1 | 2024 | 166 | 0.180 |
Why?
|
| Metabolic Diseases | 1 | 2011 | 18 | 0.180 |
Why?
|
| Lipids | 2 | 2024 | 230 | 0.170 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 537 | 0.170 |
Why?
|
| Antioxidants | 1 | 2011 | 116 | 0.160 |
Why?
|
| Garcinia mangostana | 2 | 2010 | 2 | 0.160 |
Why?
|
| Xanthones | 2 | 2010 | 2 | 0.160 |
Why?
|
| Apoptosis | 2 | 2015 | 363 | 0.150 |
Why?
|
| Titanium | 1 | 2009 | 11 | 0.150 |
Why?
|
| Protein Kinase C | 1 | 2009 | 31 | 0.150 |
Why?
|
| Vasoconstriction | 1 | 2009 | 43 | 0.150 |
Why?
|
| Humans | 17 | 2023 | 32966 | 0.150 |
Why?
|
| Receptors, LDL | 1 | 2019 | 66 | 0.150 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 47 | 0.150 |
Why?
|
| Lipopolysaccharides | 5 | 2025 | 115 | 0.140 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 156 | 0.140 |
Why?
|
| Cholesterol, Dietary | 1 | 2018 | 36 | 0.140 |
Why?
|
| Interleukin-6 | 2 | 2012 | 241 | 0.130 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 31 | 0.130 |
Why?
|
| Autophagy | 1 | 2017 | 55 | 0.130 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2017 | 57 | 0.130 |
Why?
|
| RNA, Messenger | 4 | 2015 | 500 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2007 | 81 | 0.130 |
Why?
|
| Female | 9 | 2023 | 20375 | 0.130 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 58 | 0.130 |
Why?
|
| Cardiovascular Diseases | 2 | 2015 | 1152 | 0.130 |
Why?
|
| Pancreatitis | 1 | 2006 | 18 | 0.120 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2007 | 182 | 0.110 |
Why?
|
| Absorptiometry, Photon | 2 | 2015 | 136 | 0.110 |
Why?
|
| Peroxidase | 1 | 2014 | 28 | 0.100 |
Why?
|
| Apolipoprotein A-I | 1 | 2014 | 67 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2019 | 290 | 0.100 |
Why?
|
| Diacylglycerol Kinase | 1 | 2012 | 2 | 0.100 |
Why?
|
| Pyrimidinones | 1 | 2012 | 5 | 0.100 |
Why?
|
| Thiazoles | 1 | 2012 | 27 | 0.100 |
Why?
|
| Adult | 6 | 2012 | 9586 | 0.090 |
Why?
|
| Transfection | 2 | 2009 | 185 | 0.090 |
Why?
|
| Middle Aged | 6 | 2012 | 12203 | 0.080 |
Why?
|
| Culture Media, Conditioned | 3 | 2011 | 47 | 0.080 |
Why?
|
| Flavonoids | 1 | 2010 | 19 | 0.080 |
Why?
|
| Phenols | 1 | 2010 | 18 | 0.080 |
Why?
|
| Abdominal Fat | 1 | 2010 | 47 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 101 | 0.080 |
Why?
|
| Insulin | 2 | 2018 | 369 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 475 | 0.080 |
Why?
|
| Computational Biology | 1 | 2019 | 96 | 0.070 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 141 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2010 | 226 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 1015 | 0.070 |
Why?
|
| Cell Size | 1 | 2018 | 36 | 0.070 |
Why?
|
| Genotype | 1 | 2019 | 731 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 1477 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2018 | 158 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 20 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2018 | 495 | 0.060 |
Why?
|
| Cytokines | 2 | 2011 | 247 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2025 | 43 | 0.060 |
Why?
|
| Diet, Fat-Restricted | 1 | 2015 | 31 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2025 | 64 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 50 | 0.060 |
Why?
|
| European Continental Ancestry Group | 1 | 2019 | 1163 | 0.060 |
Why?
|
| Organ Size | 1 | 2015 | 220 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2015 | 191 | 0.050 |
Why?
|
| Cell Line | 2 | 2010 | 436 | 0.050 |
Why?
|
| Endotoxins | 1 | 2024 | 37 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2013 | 24 | 0.050 |
Why?
|
| Epididymis | 1 | 2013 | 9 | 0.050 |
Why?
|
| Chemokines | 1 | 2013 | 33 | 0.050 |
Why?
|
| Phospholipase C gamma | 1 | 2013 | 6 | 0.050 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2013 | 9 | 0.050 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2013 | 8 | 0.050 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2013 | 14 | 0.050 |
Why?
|
| Linoleic Acid | 1 | 2013 | 17 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2013 | 52 | 0.050 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2013 | 23 | 0.050 |
Why?
|
| Biological Availability | 1 | 2012 | 21 | 0.050 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 28 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 33 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2013 | 97 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 259 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 125 | 0.050 |
Why?
|
| African Americans | 1 | 2019 | 1425 | 0.050 |
Why?
|
| Interleukins | 1 | 2011 | 18 | 0.040 |
Why?
|
| Cell Communication | 1 | 2011 | 29 | 0.040 |
Why?
|
| Phytotherapy | 2 | 2010 | 37 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2010 | 11 | 0.040 |
Why?
|
| Biological Transport | 1 | 2019 | 68 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2010 | 83 | 0.040 |
Why?
|
| Materials Testing | 1 | 2009 | 92 | 0.040 |
Why?
|
| Young Adult | 3 | 2010 | 2738 | 0.040 |
Why?
|
| Gene Expression | 2 | 2010 | 336 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 6 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2017 | 6 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2007 | 28 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2017 | 133 | 0.030 |
Why?
|
| Weight Gain | 1 | 2018 | 112 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 71 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2007 | 186 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 172 | 0.030 |
Why?
|
| Amylases | 1 | 2006 | 10 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2006 | 12 | 0.030 |
Why?
|
| Monocytes | 1 | 2017 | 132 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2006 | 23 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 644 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2015 | 35 | 0.030 |
Why?
|
| Mitochondria | 1 | 2017 | 214 | 0.030 |
Why?
|
| Rats | 1 | 2009 | 1610 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 837 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 17 | 0.030 |
Why?
|
| Epitopes | 1 | 2014 | 24 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2014 | 31 | 0.030 |
Why?
|
| Alanine | 1 | 2014 | 27 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 44 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 91 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 61 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 152 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 269 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2012 | 24 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 467 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 48 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 497 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 163 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 241 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2010 | 9 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2010 | 18 | 0.020 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 9 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 134 | 0.020 |
Why?
|
| Glucose | 1 | 2010 | 188 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 19 | 0.020 |
Why?
|
| Peptides | 1 | 2010 | 126 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 4065 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 10637 | 0.010 |
Why?
|